202 related articles for article (PubMed ID: 8254609)
1. Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions.
Kirby DA; Boublik JH; Rivier JE
J Med Chem; 1993 Nov; 36(24):3802-8. PubMed ID: 8254609
[TBL] [Abstract][Full Text] [Related]
2. Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues.
Kirby DA; Koerber SC; Craig AG; Feinstein RD; Delmas L; Brown MR; Rivier JE
J Med Chem; 1993 Feb; 36(3):385-93. PubMed ID: 8426366
[TBL] [Abstract][Full Text] [Related]
3. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations.
Beck-Sickinger AG; Wieland HA; Wittneben H; Willim KD; Rudolf K; Jung G
Eur J Biochem; 1994 Nov; 225(3):947-58. PubMed ID: 7957231
[TBL] [Abstract][Full Text] [Related]
4. Truncated, branched, and/or cyclic analogues of neuropeptide Y: importance of the pancreatic peptide fold in the design of specific Y2 receptor ligands.
Reymond MT; Delmas L; Koerber SC; Brown MR; Rivier JE
J Med Chem; 1992 Oct; 35(20):3653-9. PubMed ID: 1433176
[TBL] [Abstract][Full Text] [Related]
5. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
[TBL] [Abstract][Full Text] [Related]
6. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076
[TBL] [Abstract][Full Text] [Related]
7. Novel analogues of neuropeptide Y with a preference for the Y1-receptor.
Söll RM; Dinger MC; Lundell I; Larhammer D; Beck-Sickinger AG
Eur J Biochem; 2001 May; 268(10):2828-37. PubMed ID: 11358498
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships with neuropeptide Y analogues: a comparison of human Y1-, Y2- and rat Y2-like systems.
Cox HM; Tough IR; Ingenhoven N; Beck-Sickinger AG
Regul Pept; 1998 Sep; 75-76():3-8. PubMed ID: 9802388
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure, and antagonistic properties of des-Asn29[D-Trp28,32]NPY(27-36).
Balasubramaniam A; Zhai W; Tao Z; Huang Y; Fischer JE; Eden P; Taylor JE; Kar L; Samarasinghe SD; Johnson ME
Peptides; 1996; 17(7):1113-8. PubMed ID: 8959744
[TBL] [Abstract][Full Text] [Related]
10. The bioactive conformation of neuropeptide Y analogues at the human Y2-receptor.
Rist B; Ingenhoven N; Scapozza L; Schnorrenberg G; Gaida W; Wieland HA; Beck-Sickinger AG
Eur J Biochem; 1997 Aug; 247(3):1019-28. PubMed ID: 9288927
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
Beck-Sickinger AG; Jung G
Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
[TBL] [Abstract][Full Text] [Related]
12. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S
Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types.
Dumont Y; Satoh H; Cadieux A; Taoudi-Benchekroun M; Pheng LH; St-Pierre S; Fournier A; Quirion R
Eur J Pharmacol; 1993 Jul; 238(1):37-45. PubMed ID: 8405081
[TBL] [Abstract][Full Text] [Related]
14. Identification of high-potency neuropeptide Y analogues through systematic lactamization.
Kirby DA; Britton KT; Aubert ML; Rivier JE
J Med Chem; 1997 Jan; 40(2):210-5. PubMed ID: 9003519
[TBL] [Abstract][Full Text] [Related]
15. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors.
Grandt D; Schimiczek M; Rascher W; Feth F; Shively J; Lee TD; Davis MT; Reeve JR; Michel MC
Regul Pept; 1996 Nov; 67(1):33-7. PubMed ID: 8952003
[TBL] [Abstract][Full Text] [Related]
17. Structure-affinity relationships of C-terminal cyclic analogue of neuropeptide Y for the Y1-receptor.
Takebayashi Y; Koga H; Togami J; Kurihara H; Furuya T; Tanaka A; Murase K
Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1925-9. PubMed ID: 11145146
[TBL] [Abstract][Full Text] [Related]
18. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes.
Ingenhoven N; Beck-Sickinger AG
J Recept Signal Transduct Res; 1997; 17(1-3):407-18. PubMed ID: 9029504
[TBL] [Abstract][Full Text] [Related]
20. Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist.
Hoffmann S; Rist B; Videnov G; Jung G; Beck-Sickinger AG
Regul Pept; 1996 Aug; 65(1):61-70. PubMed ID: 8876037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]